TABLE 3.
Patient outcomes
| Characteristic |
Patients |
OR (95% CI), P | Adjusted OR* (95% CI), P | |
|---|---|---|---|---|
| With hyperglycemia (≥10 mmol/L) (n=17) | Without hyperglycemia (<10 mmol/L) (n=83) | |||
| Acute coronary event, n (%) | 1 (6) | 4 (5) | 1.23 (0.13–11.78), 0.86 | 1.26 (0.13–12.46), 0.85 |
| Renal failure, n (%) | 3 (18) | 10 (12) | 1.56 (0.38–6.41), 0.53 | 1.89 (0.41–8.64), 0.41 |
| Infection, n (%) | 7 (41) | 37 (45) | 0.87 (0.30–2.51), 0.80 | 0.87 (0.30–2.51), 0.80 |
| Intensive care unit admission, n (%) | 1 (6) | 9 (11) | 0.51 (0.06–4.35), 0.54 | 0.51 (0.06–4.33), 0.54 |
| Length of hospital stay, days, median (IQR) | 35 (28–51) | 30 (22–50) | N/A | N/A |
| Per cent change of length of hospital stay | N/A | N/A | 17 (−16–65), 0.35† | 17 (−17–67), 0.36† |
| Mortality, n (%) | 3 (18) | 3 (4) | 5.71 (1.04–31.22), 0.04 | 7.22 (1.08–48.29), 0.04 |
Continuous data are presented as median (Interquartile range [IQR]); categorical data are presented as n (%).
*
Adjusted for age and sex (length of hospital stay was transformed to the logarithmic form);
†
Presented are the exponentiated coefficient of the linear regression analysis to predict hospital length of stay as percentage increase/decrease (95% CI). N/A Not applicable